IL-4Rα blockade reduces influenza-associated morbidity in a murine model of allergic asthma.
Kimia ShahangianDavid A NganH H Rachel ChenYeni OhAnthony TamJing WenChung CheungDarryl A KnightDelbert R DorscheidTillie L HackettMichael R HughesKelly M McNagnyJeremy A HirotaMasahiro NiikuraS F Paul ManDon D SinPublished in: Respiratory research (2021)
Together, these data implicate allergic asthma as a significant risk factor for H1N1-related morbidity and reveal a potential therapeutic role for IL-4Rα signalling blockade in reducing the severity of influenza infection in those with allergic airway disease.